Your browser doesn't support javascript.
loading
The use of 68 Ga-PSMA PET/CT to stratify patients with PI-RADS 3 lesions according to clinically significant prostate cancer risk.
Yang, Jinhui; Tang, Yongxiang; Zhou, Chuanchi; Zhou, Ming; Li, Jian; Hu, Shuo.
Afiliación
  • Yang J; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Tang Y; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhou C; Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhou M; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li J; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hu S; Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Prostate ; 83(5): 430-439, 2023 04.
Article en En | MEDLINE | ID: mdl-36544382
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: China